Stocks 28th Nov '24 Biotech Year In Review – 2024 From obesity to new modalities, Atlas Venture’s year end presentation is a must-listen for biotech investors. You can find the slides inside Stifel’s weekly. Click to share on Twitter (Opens in new window)Click to email a link to a friend (Opens in new window)Click to share on LinkedIn (Opens in new window)
